METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT von MAYOUX, Eric Williams, WIENRICH, Marion

Volltext bestellen

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT von MAYOUX, Eric Williams, WIENRICH, Marion

Volltext bestellen

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT von MAYOUX, Eric Williams, WIENRICH, Marion

Volltext bestellen

SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS TREATED WITH NEUROLEPTIC AGENTS von MAYOUX, Eric, WIENRICH, Marion

Volltext bestellen

The Broad‐Spectrum Cation Channel Blocker Pinokalant (LOE 908 MS) Reduces Brain Infarct Volume in Rats: A Temperature‐Controlled Histological Study von Christensen, Thomas, Wienrich, Marion, Ensinger, Helmut A., Diemer, Nils Henrik

Volltext

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT von MAYOUX, Eric Williams, WIENRICH, Marion

Volltext bestellen

Ca2+-conductances in cultured rat retinal pigment epithelial cells von Strauss, Olaf, Wienrich, Marion

Volltext

Ca(2+)-conductances in cultured rat retinal pigment epithelial cells von Strauss, O, Wienrich, M

Volltext

The AMPA receptor/Na + channel blocker BIIR 561 CL is protective in a model of global cerebral ischaemia von Weiser, Thomas, Wienrich, Marion, Brenner, Michael, Kubiak, René, Weckesser, Gerhard, Palluk, Rainer

Volltext

Ca 2+ ‐conductances in cultured rat retinal pigment epithelial cells von Strauss, Olaf, Wienrich, Marion

Volltext

Talsaclidine (WAL 2014 FU), a muscarinic M1 receptor agonist for the treatment of Alzheimer's disease von Wienrich, Marion, Ceci, Angelo, Ensinger, Helmut A., Gaida, Wolfram, Mendla, Klaus D., Osugi, Takeshi, Raschig, Andreas, Weiser, Thomas

Volltext

SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS TREATED WITH NEUROLEPTIC AGENTS von WIENRICH, MARION, MAYOUX, ERIC

Volltext bestellen

METHODS OF TREATMENT AND PHARMACEUTICAL COMPOSITIONS USING AN SGLT-2 INHIBITOR AND A NEUROLEPTIC AGENT von WIENRICH MARION, MAYOUX ERIC WILLIAMS

Volltext bestellen

SGLT-2 inhibitors for treating metabolic disorders in patients treated with neuroleptic agents von WIENRICH, MARION, MAYOUX, ERIC

Volltext bestellen

Developmental regulation of AMPA-receptor properties in CA1 pyramidal neurons of rat hippocampus von Seifert, Gerald, Zhou, Min, Dietrich, Dirk, Schumacher, Thekla B., Dybek, Andre, Weiser, Thomas, Wienrich, Marion, Wilhelm, Doris, Steinhäuser, Christian

Volltext

Activation of a Cl−-Conductance by Protein Kinase-Dependent Phosphorylation in Cultured Rat Retinal Pigment Epithelial Cells von STRAUß, OLAF, STEINHAUSEN, KIRSTEN, WIENRICH, MARION, WIEDERHOLT, MICHAEL

Volltext

Talsaclidine (WAL 2014 FU), a muscarinic M 1 receptor agonist for the treatment of Alzheimer's disease von Wienrich, Marion, Ceci, Angelo, Ensinger, Helmut A., Gaida, Wolfram, Mendla, Klaus D., Osugi, Takeshi, Raschig, Andreas, Weiser, Thomas

Volltext

SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS TREATED WITH NEUROLEPTIC AGENTS von WIENRICH, MARION, MAYOUX, ERIC

Volltext bestellen

SGLT-2 INHIBITORS FOR TREATING METABOLIC DISORDERS IN PATIENTS TREATED WITH NEUROLEPTIC AGENTS von WIENRICH, MARION, MAYOUX, ERIC

Volltext bestellen

Voltage-Dependent Potassium Currents in Cultured Human Retinal Pigment Epithelial Cells von Strauss, O., Richard, G., Wienrich, M.

Volltext